Making medicine safer for people with intellectual and developmental disability
Pharmacists have the skills and capacity to support people with intellectual and developmental disabilities (IDD), but often don’t know where to start.
Speak to the...
Overcoming mythinformation
The COVID-19 pandemic is a victim of innuendo, conspiracy theories and misinformation. Pharmacists must educate patients and consumers.
Probiotics for ‘chemo brain’
Affordable and convenient probiotics may help prevent cancer-related cognitive impairment.
Digital first
Andrew Matthews MPS is the Australian Digital Health Agency’s Director of Medicines Safety. In that role, he hopes to ensure pharmacists are fundamental to healthcare’s digital future.
Opioid therapy challenges in rural Australia
For more than a decade, healthcare workers in rural and remote areas have been aware of the rising incidence of non-prescribed opioid medicines use....
TGA seeks input on benzocaine advisory statements
The Therapeutic Goods Administration (TGA) has requested comments from interested parties on the addition of a new advisory statement for labels of non-prescription medicines...